| RS2547957228 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547957230 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547957334 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547957481 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547957512 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547957527 |
GNPTAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547957564 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547957605 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547957643 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547957658 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547957743 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547957750 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547957968 |
PCCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS2547957977 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis, Mucolipidosis |
| RS2547957986 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547957990 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547958000 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547958006 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547958051 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547958062 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547958086 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547958432 |
BNC1
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2547958587 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547958606 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Pseudo-Hurler polydystrophy |
| RS2547958660 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547958662 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547958666 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis, Mucolipidosis |
| RS2547958696 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS2547958706 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547958737 |
GNPTAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547958738 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547958752 |
GNPTAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547958780 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547958783 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547958817 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547959753 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547959783 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS2547960192 |
CAMK2G
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 59, Intellectual developmental disorder 59 |
| RS2547960923 |
GNPTAB
|
Health Risk |
Pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547961071 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547961279 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547961354 |
GNPTAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547961437 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547961812 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547961828 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547961837 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547961918 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547961923 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547961931 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547962001 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547967537 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547967554 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547967574 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547967585 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547967869 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547967894 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS2547970528 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547970698 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547972361 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547972420 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547975359 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis, Mucolipidosis |
| RS2547975414 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547975422 |
GNPTAB
|
Health Risk |
Likely pathogenic |
GNPTAB-related disorder, GNPTAB-related disorder |
| RS2547975433 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547977385 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547977438 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547977587 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547978077 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547988538 |
VPS13C
|
Health Risk |
Likely pathogenic |
Young-onset Parkinson disease, Young-onset Parkinson disease |
| RS2547989462 |
GNPTAB
|
Health Risk |
Likely pathogenic |
— |
| RS2547989547 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547989559 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547989611 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547989619 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547989679 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547991854 |
ADAMTS17
|
Health Risk |
Likely pathogenic |
— |
| RS2547991857 |
ADAMTS17
|
Health Risk |
Likely pathogenic |
— |
| RS2547996966 |
AQP2
|
Health Risk |
Pathogenic |
— |
| RS2547997066 |
AQP2
|
Health Risk |
Pathogenic |
— |
| RS2547998053 |
AQP2
|
Health Risk |
Likely pathogenic |
— |
| RS2547998083 |
AQP2
|
Health Risk |
Pathogenic |
— |
| RS2547998190 |
AQP2
|
Health Risk |
Pathogenic |
— |
| RS2547998388 |
AQP2
|
Health Risk |
Likely pathogenic |
— |
| RS2547998844 |
AQP2
|
Health Risk |
Likely pathogenic |
— |
| RS2548003441 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548004546 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548018046 |
PPP1R12A
|
Health Risk |
Likely pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS2548019791 |
STAT6
|
Health Risk |
Pathogenic |
Hyper-IgE syndrome 6, autosomal dominant |
| RS2548024083 |
ADK
|
Health Risk |
Likely pathogenic |
Adenosine kinase deficiency, Adenosine kinase deficiency |
| RS2548025666 |
STAT6
|
Health Risk |
Pathogenic |
Hyper-IgE syndrome 6, autosomal dominant |
| RS2548028819 |
STAT6
|
Health Risk |
Pathogenic |
Hyper-IgE syndrome 6, autosomal dominant |
| RS2548028861 |
STAT6
|
Health Risk |
Pathogenic |
Hyper-IgE syndrome 6, autosomal dominant |
| RS2548032920 |
NRCAM
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with neuromuscular and skeletal abnormalities, Neurodevelopmental disorder with neuromuscular and skeletal abnormalities |
| RS2548053933 |
LRP1
|
Health Risk |
Pathogenic |
Developmental dysplasia of the hip 3, Developmental dysplasia of the hip 3 |
| RS2548068708 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548068713 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548068720 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548068762 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS2548068771 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2548068883 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |